Author

Antonietta Gerarda Gravina

NAVIGATING IRRITABLE BOWEL SYNDROME EPIDEMIOLOGY AND BURDEN IN MEDICAL AND NURSE STUDENTS IN THE “VANVITELLI-IBS STUDY”: GOOD ANXIETY CONTROL AND ADHERENCE TO THE MEDITERRANEAN DIET AS POSSIBLE PROTECTIVE FACTORS
NAVIGATING IRRITABLE BOWEL SYNDROME EPIDEMIOLOGY AND BURDEN IN MEDICAL AND NURSE STUDENTS IN THE “VANVITELLI-IBS STUDY”: GOOD ANXIETY CONTROL AND ADHERENCE TO THE MEDITERRANEAN DIET AS POSSIBLE PROTECTIVE FACTORS

Antonietta Gerarda Gravina  et al.

ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY
ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY

Antonietta Gerarda Gravina  et al.

HOW HAS THE SEVERE-ACUTE-RESPIRATORY-SYNDROME CORONAVIRUS 2 PANDEMIC AFFECTED ALCOHOL CONSUMPTION? A NATIONAL SURVEY FOR THE ASSESSMENT OF ALCOHOL DRINKING HABITS IN A SAMPLE OF ITALIAN CITIZENS DURING LOCKDOWN
HOW HAS THE SEVERE-ACUTE-RESPIRATORY-SYNDROME CORONAVIRUS 2 PANDEMIC AFFECTED ALCOHOL CONSUMPTION? A NATIONAL SURVEY FOR THE ASSESSMENT OF ALCOHOL DRINKING HABITS IN A SAMPLE OF ITALIAN CITIZENS DURING LOCKDOWN

Antonietta Gerarda Gravina  et al.

THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY
THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY

Antonietta Gerarda Gravina  et al.

SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?
SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?

Antonietta Gerarda Gravina  et al.

INFLUENCE OF DIABETES MELLITUS ON INFLAMMATORY BOWEL DISEASE COURSE AND TREATMENT OUTCOMES.A SYSTEMATIC REVIEW WITH META-ANALYSIS
INFLUENCE OF DIABETES MELLITUS ON INFLAMMATORY BOWEL DISEASE COURSE AND TREATMENT OUTCOMES.A SYSTEMATIC REVIEW WITH META-ANALYSIS

Antonietta Gerarda Gravina  et al.

HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT
HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT

Antonietta Gerarda Gravina  et al.

ASSESSMENT OF PHYSICAL ACTIVITY LEVELS AND ITS BARRIERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE “BE-FIT-IBD” STUDY RESULTS IN SOUTHERN EUROPE
ASSESSMENT OF PHYSICAL ACTIVITY LEVELS AND ITS BARRIERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE “BE-FIT-IBD” STUDY RESULTS IN SOUTHERN EUROPE

Antonietta Gerarda Gravina  et al.

THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION
THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION

Antonietta Gerarda Gravina  et al.

BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY
BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY

Antonietta Gerarda Gravina  et al.

VEDOLIZUMAB AS RESCUE THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS INDUCED BY SECOND-LINE CHEMOTHERAPY FOR RECURRENCE OF PLEOMORPHIC LUNG CARCINOMA
VEDOLIZUMAB AS RESCUE THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS INDUCED BY SECOND-LINE CHEMOTHERAPY FOR RECURRENCE OF PLEOMORPHIC LUNG CARCINOMA

Antonietta Gerarda Gravina  et al.

USING A JAK-STAT INHIBITOR IN MODERATE-SEVERE ULCERATIVE COLITIS ASSOCIATED WITH HIDRADENITIS SUPPURATIVA: PROBABLY NOT A FAUX PAS!
USING A JAK-STAT INHIBITOR IN MODERATE-SEVERE ULCERATIVE COLITIS ASSOCIATED WITH HIDRADENITIS SUPPURATIVA: PROBABLY NOT A FAUX PAS!

Antonietta Gerarda Gravina  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Antonietta Gerarda Gravina  et al.

Item 1 - 20 / 20
1